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adolescent breast 
ld E. Creydanus, Stephanie Stockburger, and Hatim A. Omar 
is an important organ system for the adolescent female and occasionally for 
lescent male as well. This chapter reviews basic principles of breast concerns 
ers including congenital anomalies, asymmetric breast development, under-
breasts, virginal hypertrophy, breast masses, mastaglia, galactorrhea, gyne-
a in males, and others. Clinicians should be attuned to issues and concerns for 
structure in adolescents. 
is a modified sweat gland that is enveloped by layers (superficial and deep) 
rficial fascia in the thorax; this organ system is suspended from the chest wall 
s ligaments (fibrous septae) that extend from the pectoralis fascia to the der-
progesterone, and prolactin are hormones that are important in breast 
ent as reviewed in ~Tab. 16.1. Additional key hormones include thyroxine, 
growth hormone, and adrenal corticoids. 
inician's breast examination 
often neglected by clinicians, breast examination remains an important aspect 
·cal examination process in adolescents (1,2,3,4,5). Though rare in adoles-
pain and/or a breast lump stimulate fears of breast cancer in the youth 
parents. The clinician should not ignore this system, but learn to minimize 
nt in the exam process and help the adolescent understand her body as 
ble. During the adolescent years, she can be taught about breast self-
as a way of reducing her breast cancer risk as she reaches adulthood. 
"'"''T-"''r"minations should be developed by age 20 years. 
history is important and includes asking about age, when the breast buds 
(Tanner 2 or sexual maturity rating 2) and breast growth rate as well as 
presence of nipple discharge, lesions, and pain. A menstrual history is 
nt to obtain. The female may be concerned about the size of her breasts, 
mmetry, or the timing of the growth of her breasts (precocious or delayed). 
youth may not vocalize concerns, it is important to emphasize the normalcy 
if appropriate. 
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Tab. 16.1: Impact of hormones on breast develoment. 
1. Estrogen induces the following: 
a. Ductal system growth 
b. Nipple maturation 
c. Areolar development (increased pigmentation and size) 
d. Induction of periductal fibrous tissue growth 
2. Progesterone induces alveolar maturation. 
3. Prolactin allows maturation resulting in lactation . 
16.3 Congenital anomalies 
16.3.1 Athelia and amastia 
The absence of a nipple (athelia) is a rare congenital anomaly resulting from the i 
taking exogenous androgen during pregnancy (6,7). Another rare anomaly is absence 
breast (amastia), caused by mammary ridge involution involving the pectoral ridge on 
affected side. Amastia is typically unilateral and in association with defects of the 
wall. Poland syndrome is characterized by unilateral amastia with no pectoralis mu 
development, defects of the ribs, radial nerve palsy, and webbing of the fingers. 
can be acquired after birth from inadvertent breast bed biopsy, radiation damage to 
breast, or other injury. Treatment involves surgical correction of abnormalities. 
16.3.2 Polythelia and polymastia 
Extra accessory nipples (polythelia) and accessory breast tissue (polymastia or supe 
merary breasts) are more common congenital breast anomalies found along the m 
lines from the axilla to the groin. A variety of nipple, areola, and glandular tissue 
binations can be found. Polythelia (involving nipple and areola) is noted in 1- 2 
of the general population and may be associated with cardiovascular and genitouri 
defects. The extra nipple tissue may erroneously be called a mole, while the 
breast tissue can be mistaken for hidradenitis suppurativa. Management involves su 
cal removal if the patient is concerned about cosmetic appearance. 
16.3.3 Other nipple anomalies 
A nipple that does not extend beyond the breast surface is called an inverted ni 
often bilateral and normally corrects itself within a few weeks after birth. If still 
after puberty, concerns about its appearance, frequent infection, and/or lactation 
lems may surface in the youth . Congenital nipple inversion can lead to chronic a 
abscess, characterized by nipple swelling, pain, and discharge along with peria 
erythema. Treatment involves local heat, antibiotics, and surgery in some cases 
remove the duct system. 
Acute retraction of a nipple may suggest breast disease, such as breast cancer. 
tunately, this is rare in the adolescent. Other defects include a depressed nipple 
lactiferous ducts opening into a depressed area in the areolar center) and a bifid or 
nipple. Depressed, bifid, or split nipple may also be managed surgically. 
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Asymmetric breast development 
asymmetry develops in many female adolescents, often improves as puberty 
and is noted in about 25 percent of adult females (8). It usually is a normal 
iant of breast growth with the smaller breast typically opposite to the dominant 
nd. A padded bra and reassurance is all that is needed in most cases. Once the breast 
lopment is complete on both sides, surgical correction of the asymmetry can be 
nsidered if desired and affordable. 
In adolescence, as one breast bud develops before the other, the young adolescent 
present with a unilateral mass sometimes mistaken for a tumor. Biopsy of this 
results in damage to the yet-to-mature breast and should be avoided. Damage 
a breast bud can also result from injury to this area from infection, burns, anterolat-
thoracotomy, and thoracostomy tube insertions in childhood. Burns to the chest 
usually cause skin contractu res with underlying breast tissue that is normal; release 
these contractures in the early teen years allow normal growth of the adolescent 
Also, scoliosis or defects of the rib cage can result in the appearance of breast 
metry, or pseudoasymmetry. 
Underdeveloped breasts 
mon concern among adolescent females is that of small breasts (micromastia), or 
that are much smaller than what they or society feels are normal. It is often a 
ilial condition and may be noted in those with a tall, thin body type with limited 
utaneous tissue in general and sometimes who have connective tissue disorders. 
urance of the normalcy of the breasts is important and that the "small" breasts 
not interfere with her sense of femininity, sexual relations, pregnancy, or lacta-
. Augmentation mammoplasty can be done at some time in her life when she is 
ionally, cognitively, and financially ready for such surgery. 
nilateral or bilateral hypoplasia of the breasts may be difficult to distinguish from 
cromastia. Hypoplasia or hypomastia may be due to partial end-organ response fail-
in which the breast(s) do not develop into normal breasts. Bilateral hypoplasia may 
It from androgen excess in utero or in early infant life; this may be due to congenital 
nal hyperplasia, leading to the prevention of ovarian maturation and estrogen 
retion during puberty. The nipples are smaller, less pigmented, less estrogenized, 
do not have papillae that are protuberant. The public hair may develop without 
arche, and menarche may be delayed. A careful genetic and endocrinologic eval-
on is necessary for bilateral hypoplasia. Causes include gonadal dysgenesis (Turner 
rome), androgen-producing tumor, preadolescent hypothyroidism, and gonadotro-
deficiency (pituitary hypogonadism). Poor or limited breast development may also 
It from radiation and bilateral ovariectomy. 
of the breasts results from significant weight loss and hypoestrogenemia, as 
in anorexia nervosa, chronic illness, postpartum depression, crash dieting, and 
conditions. The result is loss of breast adipose tissue and, often, severe acquired 
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breast atrophy. Scleroderma can cause local breast changes, while premature 
failure can induce secondary amenorrhea and breast atophy. The breasts 
wrinkled, flattened, and old in appearance. Treatment of breast atrophy is to 
the underlying problem. 
16.5.1 Tuberous breasts 
In this rare breast anomaly, the shape of the breasts is abnormal in which the 
breasts project forward without normal fullness; the areolar complex is overdevel 
with the appearance of herniation of breast tissue into the areola. Surgical rn•·rpr·t• 
is necessary to improve the breast appearance by reconstructing the nippl 
complex along with breast augmentation. 
16.6 Virginal hypertrophy 
Thelarche in some females leads to massive diffuse enlargement of breasts to s 
extent that it is termed juvenile, virginal, or idiopathic breast hypertrophy; even 
massive development is called macromastia or gigantomastia (9). The cause is us 
linked to individual variation, familial factors, sensitivity to estrogen and/or abno 
estrogen-progesterone ratio, and endogenous production of estrogen within 
cells. Obesity may play a role in some youth. Unilateral hypertrophy may also 
seen and can be caused by a breast neoplasm (such as a giant fibroadenoma -
section 16.7). Breasts may develop superficial changes including prominent su 
ficial veins and possibly skin necrosis. The nipple and areola may be stretch 
that they are difficult to distinguish. Complications may be worsened with a 
brassiere. 
There are no medications that are acceptable to use in adolescents. Some clinici 
have used danazol or medroxyprogesterone to reduced brease size; however, 
no clear research that these really help. Side effects of the medications (such as m 
linization and teratogenicity) prohibit their use in youth. Surgical breast reduction i 
option when the adolescent is mature enough to understand this surgery and 
potential complications. If surgery is done too early, breast enlargement may 
and negate the effects of the surgery. Breast reduction often involves reimplantatio 
the nipple-areolar complex, leading to potential lactation and nerve damage; the 
potential of breast stimulation may be reduced. 
16.7 Breast masses 
The following box, "Causes of Breast Masses in Adolescents," lists causes of b 
masses in the adolescent; 70-90 percent of masses that are biopsied are fibroadeno 
and most of the other masses are benign cysts. Since malignancy is rare in the adol 
cent, observation of a mass over a few months is usually an appropriate clin 
response. Breast cancer is noted in less than 2.5 percent of palpable breast masses 
females under 30 and less than 0.5 percent in those under age 20 years. 
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Important historical points in assessment of a breast mass include if there is asso-
pain (cyclical or noncyclical), galactorrhea, size of the lesion, and how long it 
been present. An excisional biopsy is typically obtained for a mass that is hard, 
not resolve, increases in size, fails to decrease over a few menstrual cycles, 
after aspiration, and or has bloody nipple discharge. 
lhrn::>,n<>lhnlm::> is a benign tumor arising from ducts and stoma of the terminal part of the 
system (8). It is the most common lesion noted in postpubertal females up to 
5 years of age. Fibroadenomas are typically well demarcated, encapsulated, round, rub-
and nontender. They are usually single and found in the upper, outer quadrant, 
any quadrant may be noted. As many as 20 percent have bilateral or multiple 
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tumors, in which case the condition is called fibroadenomatosis. A fibroadenoma 
2-3 em when first found but may enlarge at the end of a menstrual cycle and can 
increase during pregnancy. The ultrasound appearance is that of a smooth 
mass that is homogeneous. 
A fibroadenoma does not become malignant and does not increase the ado 
risk for malignancy later in life. If a lesion appearing to be a fibroadenoma 
decrease over 4 to 6 months, or if it continues to enlarge, excision is usually 
mended. Removal of a large mass may require more surgery to reduce the skin 
lope for a cosmetic closure. If concern is raised about potential cancer, excisi 
also suggested. 
Giant (juvenile) fibroadenoma 
A fibroadenoma that is more than 5 em is often defined as a giant or juvenile type 
important because it can grow quickly to a large size, doubling itself in 3 to 6 
tends to be seen in young adolescents, has a consistency that is softer, has more 
of superficial veins, and can cause considerable breast distortion. Though a 
tumor, it should be excised before becoming too large. 
16.7 .1 Cystosarcoma phylloides 
Cystosarcoma phylloides (phylloides tumors) is the most common malignant tumor 
breast reported in adolescents. Though a rare event in youth, the incidence is 0. 
percent of all breast tumors in adults with an incidence of metastasis of 3-12 
approximately 8 percent of these tumors occur in females under age 20 
Cystosarcoma phylloides presents as a painless, multilobular tumor that is rapidly 
ing, nonfixed, and often 8-10 em when first found. It often presents with 
discharge, venous dilation, and skin discoloration. Studies note that 10-15 
are malignant and metastases develop, particularly to the lungs. A wide exci 
2 em margins that are tumor free) is considered curative for benign tumors. 
of a malignant type includes surgery, radiation, chemotherapy, and hormonal 
Though the prognosis is poor, it is better in adolescents than in adults. 
Intraductal papilloma 
Intraductal papilloma (papillomatosis) typica lly presents as a painful, subareolar 
that is unilateral in three-fourths of cases. A serosanguineous or serous nipple d 
is often descr ibed on the affected side. In studies of breast masses in adolocr<>nt~ < 
incidence of 4 percent to 6 percent and a mean age of 17 to 18 years of age at 
tation are reported. In 30 percent of cases, a painful mass is not appreciated, 
breast palpation may compress ducts filled with tumor that leads to nipple disch 
The differential diagnosis is listed in the following box. The evaluation may i 
fine-needle aspiration, breast ultrasonography, and ductography. Intraductal papill 
is typically a benign tumor, though the adolescent patient should be followed 
for the possible development of a malignant change. 
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ry duct ectasia (periductal mastitis) refers to a condition that presents as a pain-
subareolar nodule with nipple discharge, nipple retraction, sinus tracts (or fistulae), 
d axillary lymphadenopathy. It is usually seen in adult females at menopause who 
had a history of lactation problems. It is the most common cause of acquired 
le inversion. Infection with Bacteroides sp. is seen in adolescents, leading to 
ammatory changes and periductal fibrosis and destruction of the ductal wall. 
nt includes local excision of the sinus tract or fistula along with antibiotics. 
7.2 Cystic breast disease 
I known, but less common in the adolescents are single or multiple cysts of benign 
disease. These cysts are typically not fixed to breast tissue, and aspiration reveals 
le fluid that is clear, brownish, or blood tinged . Cysts can be classified in various 
and one system is listed in the following box, including normal physiological 
nges in breast size in adolescents with up to 50 percent size change during a men-
1 cycle; these pseudolumps are normal. In the postpartum period, lactiferous ducts 
become distended and become galactoceles, presenting as a subareolar mass with 
low nipple discharge; it usually disappears with lactation, but surgical excision 
become necessary. 
Management of a breast cyst often involves fine-needle aspiration with cytological 
luation to identify if it is a matter of normal physiology or overt pathology. If the 
on disappears on aspiration, it is assumed to be a cyst, and the patient can be eval-
again in 2 to 3 months. It the lesion recurs or is solid, ultrasonography is obtained 
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for further evaluation . Sometimes an open, exisional biopsy is necessary to 
and remove the breast lesion, if aspiration is not successful or not possible. 
16.7 .3 Fibrocystic change 
Fibrocystic change (previously called fibrocystic disease) is noted in adolescents 
more commonly seen in adult females over age 35 years. It presents as firm, m 
nodularities that are cord-like and distributed diffusely in the breasts. Some 
develop " lumpy" breasts in their young adult years that may develop into 
cystic change in later adult life. Typically, there is breast tenderness before 
tion and 'change in breast size during the menstrual cycle. Sometimes, 
pain and size change may be noted. Biopsy may be necessary to identify the 
pathology. 
Management includes good brassiere support and heat. Ibuprofen may be hel 
adolescents. Oral contraceptives may offer pain relief by inhibiting progesterone 
tion, as cysts tend to be more painful in the secretory or progestational part of the 
strual cycle. Though recommended by some clinicians, there is no clear 
support for the use of vitamine E, alpha-tocopherol (600 IU/day), and dietary lim 
of methylxanthines (caffeine and other substances). Danazol, bromocriptine, 
tamoxifen have been tried in adults but have no clear indication in adolescents. 
Breast abscess 
A breast abscess presents as a painful, cystic les ion with erythema that is raised 
often indurated; there may also be mastitis (1 0) . One or multiple abscess 
noted along with fever, cellulitis, and regional lymphadenopathy. Causes of 
abscess include squeezing acne les ions, areolar hair plucking, lactation, trauma 
eluding sexual), epidermal cyst, and chronic illness with reduced host defenses. 
most common bacterial causes include Staphylococcus aureus and Strep 
though Escherichia coliPseudomonas, and other gram-negative organisms ha 
been noted. Blood cu ltures should be obtained in hospitalized patients. 
Management includes heat with warm compresses, analgesics, incision, and d 
age. Antibiotics are given seeking to cover most likely organisms and often inc 
amoxicillin-clavulanate potassium or various cephalosporins. Antibiotic regi 
should provide antistaphylococcal coverage. In more severe infections, an 
should be given parenterally. There is a 50 percent recurrence rate for i 
are delayed or only partially treated. Residual scarring may develop if there is un 
ing trauma and be mistaken for a tumor. A subareolar abscess can result in scarring 
leads to an inverted nipple. If lactational mastitis develops, breast feeding is usually 
stopped unless overt purulent nipple discharge develops. 
Mastodynia 
Mastodynia (mastalgia) refers to breast pain, often a hormonally induced process 
cyclical and associated with physiological changes characterized by nodularities 
swellings. Menstrually induced mastodynia may be due to deficient activity of the 
pus luteum produci ng a relative hyperestronism. Breast trauma (the adolescent 
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have forgotten an inciting incident), hypertrophy, and infection can cause breast 
Breast pain may also be a side effect of oral contraceptives. Other medications 
can induce painful breast enlargement include phenothiazines, resperpine, exog-
hormones, and possibly, marijuana. The differential diagnosis of mastodynia 
costochondritis, cardiac disease, and cervical spine pathology. 
agement of mastodynia includes heat, good bra support, and analgesics (includ-
the nonsteroidal anti-inflammatory agents ibuprofen or naproxen sodium) (11 ). If 
nous estrogen is an underlying cause, stop this medication. If the pain is severe 
not related to estrogen administration, cycling the menstrual periods with oral con-
'ves may be helpful. Some clinicians prescribe vitamine E (alpha-tocopherol), 
h actual benefit in this situation is not proved. Other unproven measures used 
adult females with mastodynia are evening primrose oil and the avoidance of 
nthines (found in cola, tea, or coffee), chocolate, nicotine, stress, and dairy 
I pharmacotherapeutics include danazol, bromocriptine, and tamoxifen. 
is an androgen steroid and used by some clinicians to manage severe breast 
n in adult females; it is not recommended in adolescents because it is not proved 
help. Danazol has significant side effects, such as potential masculinization and ter-
ncity. Also tried in adult females are bromocriptine (a prolactin antagonist) and 
(competes for estrogen receptors); there is no evidence of their benefit in 
lescents. If breast discomfort or pain is part of swelling and weight gain associated 
th the menstrual cycle, diuretics may help with the breast swelling and pain. 
Mondor's disease is superficial thrombophlebitis of the thoracoepigastric vein seen 
pregnancy and various types of trauma (including biopsy or breast surgery). It pre-
with painful cords of phlebitis palpated over the involved breast, typically in the 
, lateral breast area. It typically fully resolves in 10 to 21 days, and management 
eludes local heat along with oral analgesics. 
Nipple discharge 
of nipple discharge are listed in the following box (12). A yellow discharge is 
with normal physiological effects or a galactocele, while a clear, serous, or green-
discharge suggests a physiological cyst. If the discharge is milky, consider such 
uses as lactation, breast cancer, microadenoma, elevated thyroid stimulating hor-
one, acromegaly, or phenothiazine effects. A bloody nipple discharge may be due 
cystosarcoma phylloides, papillary carcinoma, intraductal papilloma, or cystic due-
hyperplasia. A brownish nipple discharge is noted with Montgomery gland secretion 
intraductal papilloma, while a purulent discharge is associated with infection. 
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When evaluating an adolescent with a nipple discharge, the clinician should 
careful history that includes the amount and color of the nipple discharge, associated 
abnormalities, and any history for trauma, breast manipulation, or menstrual 
Examine the breasts (including the nipples) carefully. A ductogram (galactograph) 
be helpful. Surgery may be necessary to remove the involved areolar duct to be 
rare malignancy is not present, such as cytosarcoma phylloides or papillary 
Galactorrhea 
Galactorrhea is breast milk secretion unrelated to pregnancy or nursing that 
more than 1 year after nursing. The fluid may be clear, white or milky, green, or 
it varies in amount, and a Sudan stain reveals fat globules. IJi>-Tab. 16.2 lists 
Tab. 16.2: Causes of galactorrhea. 
Recent pregnancy terminated by spontaneous or induced abortion 
Neurogenic 
Chest wall disorders 
Bronchiectasis and chronic bronchitis 
Herpes zoster 
Chronic crutch use 
Thoracotomy or thoracoplasty 
Burns to chest wall 
Breast (nipple) manipulation or stimulation 
Chronic inflammatory disease or abscess of breast 
Psychogenic, including pseudocyesis and pseudonursing 
Miscellaneous 
Hysterectomy or uterine tumors 
Laparotomy 
Spinal cord disorders and surgery 
Idiopathic normoprolactinemic, with or without amenorrhea 
Central nervous system abnormalities 
Diffuse brain disease 
Coma 
Pseudotumor cerebri 
Encephalitis and sequelae 
Uremia 
Tumors, infiltrations, structural abnormalities 
Neurocutaneous syndromes 
Craniopharyngioma 
l );Tab. 16.2: Causes of galactorrhea. (Continued) 
B:PPineal tumors 
()ther intracranial tumors, cysts, and masses 
,, Histiocytosis X 
Sarcoidosis 
c Pituitary 
Stalk section 
, Empty sella syndrome 
Pituitary infarction and Sheehan syndrome 
Hyperprolactinemi a with or without prolactinoma 
''Other functional pituitary tumors 
Hypo- and hyperthyroidism 
Chronic renal disease 
Adrenal tumors and hypernephromas 
Cirrhosis 
Nelson syndrome 
Acute intermittent porphyria 
Testicular and ovarian tumors 
16.8 Nipple discharge 
Contraceptive pill s, including other estrogen or progesterone 
Polycystic ovary syndrome 
Starvation or refeeding (including anorexia nervosa) 
Cushing's d isease 
Hypogonadism 
Drugs 
• Phenothiazines, thioxa nthines, other major tranquili zers 
• Tricyclic antidepressants 
• Opiates, including codeine and heroin 
• Monoamine oxidase inhibitors 
• Amphetamines 
• Chlordiazepoxide 
• Meprobamate 
• Metoclopramide 
• Bromocriptine withdrawal 
• Cimetidine and ranitidine 
• Tamoxifen 
• Verapamil 
• Isoniazid 
• Estrogens 
• Oth~r psychotropic drugs 
• Other chemotherapy drugs (cisplatin, cytosine arabinoside, adriamycin) 
I 295 
Reprinted, with permission from: Greydanus DE, Shearin RB . Adolescent sexuality and gynecology. 
Philade lphia: Lea & Febiger, 1990:145. 
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galactorrhea, though the most frequent are idiopathic (benign), self-manipulation, 
macological, prolactinoma, and hypothyroidism. A variety of medications or 
induce hyperprolactinemia, including those that block dopamine receptors 
antidepressants, butyrophenones, and phenothiazines), deplete dopamine (as 
stimulate lactotrophs (narcotics, verapamil, and high dose estrogens), and 
dopamine receptors in the gastrointestinal tract (metoclopramide). Galactorrh 
be induced by oral contraceptives, reserpine, spironolactone, 
and others. Mar ijuana has been implicated but is not proved as a cause. 
The adolescent who presents with galactorrhea needs a careful evaluation 
many causes that are possible, as noted in ~Tab. 16.2. The history should 
drug abuse, menstrual abnormality, breast stimulation, headaches, visual di 
thyroid disorder, and other factors. Depending on history and physical exam, 
prolactin and thyroid levels is prudent. ACT or MRI of the sella turcica may be i 
tests to obtain. Additional testing may be necessary depending on the precise find 
The management depends on the underlying etiology. Underlying thyroid 
tion or menstrual abnormality should be treated. Management of a microade 
often with a dopamine agonist, as bromocriptine, and if necessary, surgery. 
drugs or medications should be stopped, as should be self-manipulation or stimu 
if causative. Careful follow-up is important, and consultation with experts is 
for severe, confusing, or cases resistant to treatment. 
Gynecomastia 
Gynecomastia is a proliferation of the glandular tissue of the male breast and 
neonatal, prepubertal, or pubertal. Transient breast development is noted in 
cent of adolescent males and may be linked to transient imbalances in endogenous 
duction of estrogen (relative excess) and testosterone (relative deficiency) with end 
sensitivity. The most common type consists of a small, tender, firm, discoid su 
mass measuring 2 to 3 em in diameter, which is referred to as type 1 
benign adolescent hypertrophy. Type 2 gynecomastia is a more generalized 
enlargement approximating Tanner stage 3 or even stage 4 breast development 
adolescent girls. 
Besides idiopathic gynecomastia, pseudogynecomastia may occur in obese 
males with the deposition offat in the breast region or in youth with well-devel 
toralis muscles. If gynecomastia occurs at a time other than between Tanner 2 
pubertal stages, other causes should be considered. Such causes are often 
as hypothalamic, pituitary, endocrine (hormonal), or drug induced. Hypogon 
as seen in Klinefelter's syndrome, must be ruled out. Klinefelter's syndrome 
sent with gynecomastia and small testes. Other pituitary-gonadal endocrinopath 
also be implicated, including pituitary, adrenal, or testicular tumors. A wide 
drugs have also been implicated including estrogens (which may be taken as 
drugs by some gay youths) and others I isted in ~Tab. 16.3. 
A careful evaluation is necessary for youth with gynecomastia. The hi 
include drugs/medications, family history, duration of the gynecomastia, weight 
and systemic disease symptomatology. The physical examination must include 
staging and size of each breast, testicular exam, and abdominal and 
exams. Height, weight, and vital signs are also important. 
16.3: Causes of gynecomastia. 
Familial gynecomastia 
. Klinefelter's syndrome 
Androgen insensitivity syndrome 
Hodgkin's disease 
Pituitary tumor 
Adrenal tumor 
Thyroid dysfunction (hypo/hyperthyroidism) 
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Miscellaneous tumors (teratoma, seminoma, Leyd ig-cell tumor, hepatoma, bronchogenic 
carcinoma, others) 
Cirrhosis of the I iver 
Chronic glomerulonephritis 
. Male pseudohermaphroditism 
Leukemia 
Traumatic paraplegia 
Starvation (on refeeding) 
lfan (and other chemotherapeutic agents) 
rinted and modified, with permission: Greydanus DE, Shearin RB. Adolescent sexuality 
gynecology. Philadelphia: Lea & Febiger, 1990:148. 
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Treatment of normal physiological gynecomastia consists, first, of 
boy that his hormones have not gone awry and that some mysterious intern 
sion has not confused his sex. Mild forms, or stage 1 gynecomastia, require 
more. Boys who are singularly upset or bordering on homosexual panic (a not 
mon normal developmental stage in the young adolescent that is likely to be 
bated by gynecomastia) may need additional counseling, emotional 
possibly a medical excuse (based on some other less compromising cause) 
ical education classes to avoid the overwhelming anxi ety that may be encou 
the locker room . 
Any gynecomastia-inducing drug that is being taken should be in<>•nrll·,,r, _· 
stopped. Type 2 gynecomastia deserves surgical correction as soon as it is a 
that resolution will not occur (that is, after observation for 6 to 12 months). 
therapy (as with testosterone, tamoxifen, clomiphene, or danazol) is not 
commended for adolescents. Testosterone has been used for the gynecomasti 
in Klinefelter' s syndrome, and antiestrogenic medications (tamoxifen and clomi 
have been used in some adults with gynecomastia. 
16.9 Summary 
This chapter has reviewed important issues and disorders in the adolescent b 
an organ system with complex ties to sexuality and potential pathology. The 
lescent female may present with concerns of having too large or too small b 
breast pain, breast mass, or other issues as noted in this chapter. Concerns 
are raised should be addressed with a comprehensive yet sensitive h · 
physical examination. Pharmacological management is also concerned 
appropriate. 
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